Utah Medical Products Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Kevin Cornwell
Chief executive officer
US$510.6k
Total compensation
| CEO salary percentage | 29.8% |
| CEO tenure | 32yrs |
| CEO ownership | 5.6% |
| Management average tenure | no data |
| Board average tenure | 27.4yrs |
Recent management updates
Recent updates
Utah Medical Products: Favorably Skewed Risk/Reward Profile
Dec 26Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30
Aug 06
Utah Medical Products: An Attractive, But Speculative, Prospect
Mar 22Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30
Feb 09Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30
Dec 13Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30
Nov 23Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.30
Nov 03Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of $0.295
Aug 28Do Utah Medical Products' (NASDAQ:UTMD) Earnings Warrant Your Attention?
Mar 04Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.295
Feb 10A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)
Jan 11Utah Medical Products (NASDAQ:UTMD) Will Pay A Dividend Of $0.29
Aug 08Utah Medical Products declares $0.29 dividend
Aug 02Utah Medical Products GAAP EPS of $1.12, revenue of $13.4M
Jul 26Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29
May 14Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.29
Feb 26Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29
Feb 12Utah Medical Products (NASDAQ:UTMD) Could Be Struggling To Allocate Capital
Sep 28Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28
Aug 06Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation
May 01Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?
Mar 26Here's What To Make Of Utah Medical Products' (NASDAQ:UTMD) Returns On Capital
Mar 02Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 11Utah Medical Products (NASDAQ:UTMD) Shareholders Have Enjoyed A 47% Share Price Gain
Jan 27
Should You Review Recent Insider Transactions At Utah Medical Products, Inc. (NASDAQ:UTMD)?
Jan 13Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shareholder Ownership Skewed Towards Insiders?
Dec 29Is Utah Medical Products, Inc. (NASDAQ:UTMD) A Smart Pick For Income Investors?
Dec 15Will Utah Medical Products (NASDAQ:UTMD) Multiply In Value Going Forward?
Nov 30Utah Medical Products declares $0.285 dividend
Nov 03CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$15m |
| Jun 30 2024 | n/a | n/a | US$16m |
| Mar 31 2024 | n/a | n/a | US$16m |
| Dec 31 2023 | US$511k | US$152k | US$17m |
| Sep 30 2023 | n/a | n/a | US$17m |
| Jun 30 2023 | n/a | n/a | US$17m |
| Mar 31 2023 | n/a | n/a | US$17m |
| Dec 31 2022 | US$452k | US$84k | US$16m |
| Sep 30 2022 | n/a | n/a | US$16m |
| Jun 30 2022 | n/a | n/a | US$16m |
| Mar 31 2022 | n/a | n/a | US$15m |
| Dec 31 2021 | US$494k | US$156k | US$15m |
| Sep 30 2021 | n/a | n/a | US$14m |
| Jun 30 2021 | n/a | n/a | US$13m |
| Mar 31 2021 | n/a | n/a | US$11m |
| Dec 31 2020 | US$327k | US$78k | US$11m |
| Sep 30 2020 | n/a | n/a | US$12m |
| Jun 30 2020 | n/a | n/a | US$13m |
| Mar 31 2020 | n/a | n/a | US$15m |
| Dec 31 2019 | US$474k | US$156k | US$15m |
| Sep 30 2019 | n/a | n/a | US$14m |
| Jun 30 2019 | n/a | n/a | US$17m |
| Mar 31 2019 | n/a | n/a | US$18m |
| Dec 31 2018 | US$501k | US$156k | US$19m |
| Sep 30 2018 | n/a | n/a | US$13m |
| Jun 30 2018 | n/a | n/a | US$10m |
| Mar 31 2018 | n/a | n/a | US$9m |
| Dec 31 2017 | US$501k | US$156k | US$9m |
Compensation vs Market: Kevin's total compensation ($USD510.57K) is below average for companies of similar size in the US market ($USD1.38M).
Compensation vs Earnings: Kevin's compensation has been consistent with company performance over the past year.
CEO
Kevin Cornwell (77 yo)
32yrs
Tenure
US$510,570
Compensation
Mr. Kevin L. Cornwell has been the Chairman of the Board at Utah Medical Products Inc. since 1996 and its President and Chief Executive Officer since December 1992. Mr. Cornwell has been Secretary of Utah...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 31.9yrs | US$510.57k | 5.56% $ 11.7m | |
| Independent Director | 26.9yrs | US$29.40k | 0.63% $ 1.3m | |
| Independent Lead Director | 28.9yrs | US$37.80k | 0.15% $ 309.4k | |
| Independent Director | 27.9yrs | US$29.40k | 0.14% $ 299.4k | |
| Independent Director | 17.8yrs | US$29.40k | 0.39% $ 812.3k | |
| Director | less than a year | no data | 0.0015% $ 3.1k |
27.4yrs
Average Tenure
77yo
Average Age
Experienced Board: UTMD's board of directors are seasoned and experienced ( 27.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 09:47 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Utah Medical Products, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joseph Munda | Sidoti & Company, LLC |